Novo Nordisk Slips On Analyst Warning Of Weaker Wegovy Sales
Novo Nordisk stock fell after a JPMorgan analyst said sales of its blockbuster weight-loss drug may be weaker-than-expected. The post Novo Nordisk Slips On Analyst Warning Of Weaker Wegovy Sales appeared first on Investor's Business Daily.
Novo Nordisk stock fell after a JPMorgan analyst said sales of its blockbuster weight-loss drug may be weaker-than-expected.
The post Novo Nordisk Slips On Analyst Warning Of Weaker Wegovy Sales appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
